Fibrocor Therapeutics appoints William P. Newsome III as CEO and Piet Wigerinck as Chief Scientific Advisor
Seasoned biopharmaceutical executive to lead Fibrocor as it aims to reshape the future of fibrosis treatment Fibrocor is currently advancing three drug candidates for fibrotic diseases into the clinic Toronto, Canada – 25 October 2023 […]